1. Home
  2. SDGR vs NABL Comparison

SDGR vs NABL Comparison

Compare SDGR & NABL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SDGR
  • NABL
  • Stock Information
  • Founded
  • SDGR 1990
  • NABL 2000
  • Country
  • SDGR United States
  • NABL United States
  • Employees
  • SDGR 787
  • NABL N/A
  • Industry
  • SDGR Biotechnology: Pharmaceutical Preparations
  • NABL Computer Software: Prepackaged Software
  • Sector
  • SDGR Health Care
  • NABL Technology
  • Exchange
  • SDGR Nasdaq
  • NABL Nasdaq
  • Market Cap
  • SDGR 1.5B
  • NABL 1.5B
  • IPO Year
  • SDGR 2020
  • NABL N/A
  • Fundamental
  • Price
  • SDGR $19.77
  • NABL $7.78
  • Analyst Decision
  • SDGR Buy
  • NABL Buy
  • Analyst Count
  • SDGR 8
  • NABL 4
  • Target Price
  • SDGR $26.75
  • NABL $9.31
  • AVG Volume (30 Days)
  • SDGR 1.2M
  • NABL 612.6K
  • Earning Date
  • SDGR 11-05-2025
  • NABL 11-06-2025
  • Dividend Yield
  • SDGR N/A
  • NABL N/A
  • EPS Growth
  • SDGR N/A
  • NABL N/A
  • EPS
  • SDGR N/A
  • NABL 0.01
  • Revenue
  • SDGR $237,917,000.00
  • NABL $482,397,000.00
  • Revenue This Year
  • SDGR $22.73
  • NABL $9.79
  • Revenue Next Year
  • SDGR $19.85
  • NABL $8.97
  • P/E Ratio
  • SDGR N/A
  • NABL $751.40
  • Revenue Growth
  • SDGR 18.59
  • NABL 7.40
  • 52 Week Low
  • SDGR $16.60
  • NABL $6.07
  • 52 Week High
  • SDGR $28.47
  • NABL $13.04
  • Technical
  • Relative Strength Index (RSI)
  • SDGR 45.00
  • NABL 47.02
  • Support Level
  • SDGR $20.10
  • NABL $7.56
  • Resistance Level
  • SDGR $21.23
  • NABL $7.88
  • Average True Range (ATR)
  • SDGR 1.07
  • NABL 0.20
  • MACD
  • SDGR -0.20
  • NABL -0.01
  • Stochastic Oscillator
  • SDGR 17.93
  • NABL 31.69

About SDGR Schrodinger Inc.

Schrodinger Inc is a healthcare-based software company. Its operating segments are Software and Drug discovery. Through the Software segment, the company is focused on selling software to transform drug discovery across the life sciences industry and customers in materials science industries. In the Drug discovery segment, it is engaged in generating revenue from a portfolio of preclinical and clinical programs, internally and through collaborations. It generates revenue from the sales of software solutions and from research funding and milestone payments from its drug discovery collaborations.

About NABL N-able Inc.

N-able Inc is a provider of cloud-based software solutions for managed service providers (MSPs), enabling them to support digital transformation and growth for small and medium-sized enterprises. With a flexible technology platform and powerful integrations, N-able makes it easy for MSPs to monitor, manage, and protect their end-customer systems, data, and networks. The company's growing portfolio of management, security, automation, and data protection solutions is built for IT services management professionals. Geographically, the majority of revenue is from the United States. The company also has a presence in the United Kingdom and all other International regions.

Share on Social Networks: